Royalty Pharma 再次上调业绩指引，目标 2026 年投资组合收入达 34 亿至 35 亿美元 (NASDAQ:RPRX)
· seekingalpha.com
Royalty Pharma (RPRX) 2026 年第二季度财报电话会议：上调业绩指引，现金流强劲，已部署 11 亿美元资金。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...